[1]
|
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L. and Azziz, R. (2016) Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome. Fertility and Sterility, 106, 6-15. https://doi.org/10.1016/j.fertnstert.2016.05.003
|
[2]
|
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E. and Yildiz, B.O. (2016) The Prevalence and Phenotypic Features of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. Human Reproduction, 31, 2841-2855. https://doi.org/10.1093/humrep/dew218
|
[3]
|
Chen, X., Yang, D., Mo, Y., Li, L., Chen, Y. and Huang, Y. (2008) Prevalence of Polycystic Ovary Syndrome in Unselected Women from Southern China. European Journal of Obstetrics & Gynecology and Reproductive Biology, 139, 59-64. https://doi.org/10.1016/j.ejogrb.2007.12.018
|
[4]
|
Teede, H.J., Tay, C.T., Laven, J.J.E., Dokras, A., Moran, L.J., Piltonen, T.T., et al. (2023) Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 108, 2447-2469. https://doi.org/10.1210/clinem/dgad463
|
[5]
|
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS). Human Reproduction, 19, 41-47. https://doi.org/10.1093/humrep/deh098
|
[6]
|
Diamanti-Kandarakis, E., Kouli, C.R., Bergiele, A.T., Filandra, F.A., Tsianateli, T.C., Spina, G.G., et al. (1999) A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic Profile. The Journal of Clinical Endocrinology & Metabolism, 84, 4006-4011. https://doi.org/10.1210/jcem.84.11.6148
|
[7]
|
Goodarzi, M.O., Carmina, E. and Azziz, R. (2015) DHEA, DHEAS and PCOS. The Journal of Steroid Biochemistry and Molecular Biology, 145, 213-225. https://doi.org/10.1016/j.jsbmb.2014.06.003
|
[8]
|
van Hooff, M.H.A., Voorhorst, F.J., Kaptein, M.B., Hirasing, R.A., Koppenaal, C. and Schoemaker, J. (2004) Predictive Value of Menstrual Cycle Pattern, Body Mass Index, Hormone Levels and Polycystic Ovaries at Age 15 Years for Oligo-Amenorrhoea at Age 18 Years. Human Reproduction, 19, 383-392. https://doi.org/10.1093/humrep/deh079
|
[9]
|
Hayes, M.G., Urbanek, M., Ehrmann, D.A., Armstrong, L.L., Lee, J.Y., Sisk, R., et al. (2015) Genome-Wide Association of Polycystic Ovary Syndrome Implicates Alterations in Gonadotropin Secretion in European Ancestry Populations. Nature Communications, 6, Article No. 7502. https://doi.org/10.1038/ncomms8502
|
[10]
|
Zhang, X., Yeung, D.C.Y., Karpisek, M., Stejskal, D., Zhou, Z., Liu, F., et al. (2008) Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated with the Metabolic Syndrome in Humans. Diabetes, 57, 1246-1253. https://doi.org/10.2337/db07-1476
|
[11]
|
Myers, S.H., Montanino Oliva, M., Nordio, M. and Unfer, V. (2024) PCOS Phenotype Focus: Phenotype D under the Magnifying Glass. Archives of Gynecology and Obstetrics, 309, 2307-2313. https://doi.org/10.1007/s00404-024-07408-2
|
[12]
|
Siddiqui, S., Mateen, S., Ahmad, R. and Moin, S. (2022) A Brief Insight into the Etiology, Genetics, and Immunology of Polycystic Ovarian Syndrome (PCOS). Journal of Assisted Reproduction and Genetics, 39, 2439-2473. https://doi.org/10.1007/s10815-022-02625-7
|
[13]
|
Ji, R., Jia, F., Chen, X., Gao, Y. and Yang, J. (2023) Carnosol Inhibits KGN Cells Oxidative Stress and Apoptosis and Attenuates polycystic Ovary Syndrome Phenotypes in Mice through Keap1‐Mediated Nrf2/HO‐1 Activation. Phytotherapy Research, 37, 1405-1421. https://doi.org/10.1002/ptr.7749
|
[14]
|
Vatier, C. and Christin-Maitre, S. (2024) Epigenetic/Circadian Clocks and PCOS. Human Reproduction, 39, 1167-1175. https://doi.org/10.1093/humrep/deae066
|
[15]
|
Carmina, E. and Longo, R.A. (2022) Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 to 29 Years. Cells, 11, Article 3255. https://doi.org/10.3390/cells11203255
|
[16]
|
Hamaguchi, M., Nishio, M., Toyama, T., Sugiura, H., Kondo, N., Fujii, Y., et al. (2008) Possible Difference in Frequencies of Genetic Polymorphisms of Estrogen Receptor, Estrogen Metabolism and P53 Genes between Estrogen Receptor-Positive and-Negative Breast Cancers. Japanese Journal of Clinical Oncology, 38, 734-742. https://doi.org/10.1093/jjco/hyn097
|
[17]
|
Stamatiades, G.A. and Kaiser, U.B. (2018) Gonadotropin Regulation by Pulsatile GnRH: Signaling and Gene Expression. Molecular and Cellular Endocrinology, 463, 131-141. https://doi.org/10.1016/j.mce.2017.10.015
|
[18]
|
孔小娟, 乔江, 雷磊. 苍附导痰汤加减治疗多囊卵巢综合征伴胰岛素抵抗(痰湿证)的临床研究[J]. 中药新药与临床药理, 2025, 36(5): 806-813.
|
[19]
|
Lerchbaum, E., Schwetz, V., Rabe, T., Giuliani, A. and Obermayer-Pietsch, B. (2014) Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype. PLOS ONE, 9, e108263. https://doi.org/10.1371/journal.pone.0108263
|
[20]
|
王杜娟, 杨芸. 多囊卵巢综合征患者中血清脂联素、瘦素水平与胰岛素抵抗的相关性分析[J]. 实用妇科内分泌电子杂志, 2023, 10(16): 18-20.
|
[21]
|
Luo, P., Cao, Y., Li, P., Li, W., Song, Z., Fu, Z., et al. (2022) Tyg Index Performs Better than HOMA-IR in Chinese Type 2 Diabetes Mellitus with a BMI < 35 kg/m2: A Hyperglycemic Clamp Validated Study. Medicina, 58, Article 876. https://doi.org/10.3390/medicina58070876
|
[22]
|
Acosta-Martinez, M. and Cabail, M.Z. (2022) The PI3K/Akt Pathway in Meta-Inflammation. International Journal of Molecular Sciences, 23, Article 15330. https://doi.org/10.3390/ijms232315330
|
[23]
|
Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., et al. (2002) Androgens Decrease Plasma Adiponectin, an Insulin-Sensitizing Adipocyte-Derived Protein. Diabetes, 51, 2734-2741. https://doi.org/10.2337/diabetes.51.9.2734
|
[24]
|
李春梅, 罗玮. 2型糖尿病相关致病基因的作用机制研究进展[J]. 山东医药, 2024, 64(14): 95-100.
|
[25]
|
Kazer, R.R., Kessel, B. and Yen, S.S.C. (1987) Circulating Luteinizing Hormone Pulse Frequency in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 65, 233-236. https://doi.org/10.1210/jcem-65-2-233
|
[26]
|
Díaz, M., de Zegher, F. and Ibáñez, L. (2023) Circulating Follistatin Concentrations in Adolescent PCOS: Divergent Effects of Randomized Treatments. Frontiers in Endocrinology, 14, Article 1125569. https://doi.org/10.3389/fendo.2023.1125569
|
[27]
|
Dapas, M., Lin, F.T.J., Nadkarni, G.N., Sisk, R., Legro, R.S., Urbanek, M., et al. (2020) Distinct Subtypes of Polycystic Ovary Syndrome with Novel Genetic Associations: An Unsupervised, Phenotypic Clustering Analysis. PLOS Medicine, 17, e1003132. https://doi.org/10.1371/journal.pmed.1003132
|
[28]
|
Silveira, M.A., Burger, L.L., DeFazio, R.A., Wagenmaker, E.R. and Moenter, S.M. (2016) GnRH Neuron Activity and Pituitary Response in Estradiol-Induced vs Proestrous Luteinizing Hormone Surges in Female Mice. Endocrinology, 158, 356-366. https://doi.org/10.1210/en.2016-1771
|
[29]
|
Watanabe, Y., Fisher, L., Campbell, R.E. and Jasoni, C.L. (2023) Defining Potential Targets of Prenatal Androgen Excess: Expression Analysis of Androgen Receptor on Hypothalamic Neurons in the Fetal Female Mouse Brain. Journal of Neuroendocrinology, 35, e13302. https://doi.org/10.1111/jne.13302
|
[30]
|
Huang, Y., Gao, J., Zhang, C., Zhao, H., Zhao, Y., Li, R., et al. (2016) Assessment of Growth and Metabolism Characteristics in Offspring of Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Adults. Reproduction, 152, 705-714. https://doi.org/10.1530/rep-16-0081
|
[31]
|
Appiah Adu-Gyamfi, E., Tanam Djankpa, F., Nelson, W., Czika, A., Kumar Sah, S., Lamptey, J., et al. (2020) Activin and Inhibin Signaling: From Regulation of Physiology to Involvement in the Pathology of the Female Reproductive System. Cytokine, 133, Article ID: 155105. https://doi.org/10.1016/j.cyto.2020.155105
|
[32]
|
吴鑫. 不同表型多囊卵巢综合征与AMH、性激素、DHEAs、AND之间的相关性研究[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2023.
|
[33]
|
Wang, Y., An, H., Liu, T., Qin, C., Sesaki, H., Guo, S., et al. (2019) Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK. Cell Reports, 29, 1511-1523.e5. https://doi.org/10.1016/j.celrep.2019.09.070
|
[34]
|
Moeckli, B., Pham, T., Slits, F., Latrille, S., Peloso, A., Delaune, V., et al. (2022) FGF21 Negatively Affects Long-Term Female Fertility in Mice. Heliyon, 8, e11490. https://doi.org/10.1016/j.heliyon.2022.e11490
|
[35]
|
Liang, F., Chen, Y., Pan, X., Xia, Z. and Yuan, D. (2023) A New Synthesis of D-Lyxose from D-Arabinose. Carbohydrate Research, 526, Article ID: 108782. https://doi.org/10.1016/j.carres.2023.108782
|
[36]
|
Shand, J. and Cutfield, R. (2023) Multiple Diabetes Autoantibodies Following an Episode of Acute Pancreatitis. New Zealand Medical Journal, 136, 90-92. https://doi.org/10.26635/6965.6056
|
[37]
|
Shah, B., Chen, J.M.H., Wu, J.J., Feng, C., Zhou, L., Park, J.E., et al. (2023) Matching-Adjusted Indirect Comparisons of Brexucabtagene Autoleucel with Alternative Standard Therapies for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients. Advances in Therapy, 40, 5383-5398. https://doi.org/10.1007/s12325-023-02662-3
|
[38]
|
Tinguely, C., Paulméry, M., Terrettaz, C. and Gonzalez, D. (2023) Diurnal Cycles Drive Rhythmic Physiology and Promote Survival in Facultative Phototrophic Bacteria. ISME Communications, 3, Article No. 125. https://doi.org/10.1038/s43705-023-00334-5
|
[39]
|
Zhao, Y., Lan, Y., Liu, L., Hao, J., Wang, H. and Ji, L. (2024) Efficacy of Acupuncture in Animal Models of Various Ovarian Dysfunctions: A Systematic Review and Meta-Analysis. Frontiers in Medicine, 11, Article 1348884. https://doi.org/10.3389/fmed.2024.1348884
|
[40]
|
Kokoris, G.J., Lam, N.Y., Ferin, M., Silverman, A. and Gibson, M.J. (1988) Transplanted Gonadotropin-Releasing Hormone Neurons Promote Pulsatile Luteinizing Hormone Secretion in Congenitally Hypogonadal (HPG) Male Mice. Neuroendocrinology, 48, 45-52. https://doi.org/10.1159/000124988
|
[41]
|
Baskind, N.E. and Balen, A.H. (2016) Hypothalamic-Pituitary, Ovarian and Adrenal Contributions to Polycystic Ovary Syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology, 37, 80-97. https://doi.org/10.1016/j.bpobgyn.2016.03.005
|
[42]
|
Moran, C., Reyna, R., Boots, L.S. and Azziz, R. (2004) Adrenocortical Hyperresponsiveness to Corticotropin in Polycystic Ovary Syndrome Patients with Adrenal Androgen Excess. Fertility and Sterility, 81, 126-131. https://doi.org/10.1016/j.fertnstert.2003.07.008
|
[43]
|
Kumariya, S., Ubba, V., Jha, R.K. and Gayen, J.R. (2021) Autophagy in Ovary and Polycystic Ovary Syndrome: Role, Dispute and Future Perspective. Autophagy, 17, 2706-2733. https://doi.org/10.1080/15548627.2021.1938914
|
[44]
|
Michelmore, K., Ong, K., Mason, S., Bennett, S., Perry, L., Vessey, M., et al. (2001) Clinical Features in Women with Polycystic Ovaries: Relationships to Insulin Sensitivity, Insulin Gene VNTR and Birth Weight. Clinical Endocrinology, 55, 439-446. https://doi.org/10.1046/j.1365-2265.2001.01375.x
|
[45]
|
Boyer, A., Lapointe, É., Zheng, X., Cowan, R.G., Li, H., Quirk, S.M., et al. (2010) WNT4 Is Required for Normal Ovarian Follicle Development and Female Fertility. The FASEB Journal, 24, 3010-3025. https://doi.org/10.1096/fj.09-145789
|
[46]
|
Zhou, J., Jiang, Z., Fu, L., Qu, F., Dai, M., Xie, N., et al. (2023) Contribution of Labor Related Gene Subtype Classification on Heterogeneity of Polycystic Ovary Syndrome. PLOS ONE, 18, e0282292. https://doi.org/10.1371/journal.pone.0282292
|
[47]
|
Moravek, M.B., Yin, P., Ono, M., Coon V, J.S., Dyson, M.T., Navarro, A., et al. (2014) Ovarian Steroids, Stem Cells and Uterine Leiomyoma: Therapeutic Implications. Human Reproduction Update, 21, 1-12. https://doi.org/10.1093/humupd/dmu048
|
[48]
|
Mostinckx, L., Goyens, E., Mackens, S., Roelens, C., Boudry, L., Uvin, V., et al. (2024) Clinical Outcomes from ART in Predicted Hyperresponders: In Vitro Maturation of Oocytes versus Conventional Ovarian Stimulation for IVF/ICSI. Human Reproduction, 39, 586-594. https://doi.org/10.1093/humrep/dead273
|
[49]
|
Carmina, E., Longo, A. and Lobo, R.A. (2003) Does Ovarian Blood Flow Distinguish between Ovulatory and Anovulatory Patients with Polycystic Ovary Syndrome? American Journal of Obstetrics and Gynecology, 189, 1283-1286. https://doi.org/10.1067/s0002-9378(03)00832-9
|
[50]
|
Zhang, J., Yu, H., Fan, Y., Wu, L., Fang, Y., Wei, Z., et al. (2024) Integrated Stress Response Mediates HSP70 to Inhibit Testosterone Synthesis in Aging Testicular Leydig Cells. Reproductive Biology, 24, Article ID: 100954. https://doi.org/10.1016/j.repbio.2024.100954
|
[51]
|
Chapman, A.J., Wilson, M.D., Obhrai, M., Sawers, R.S., Lynch, S.S., Royston, J.P., et al. (1987) Effect of Bromocriptine on LH Pulsatility in the Polycystic Ovary Syndrome. Clinical Endocrinology, 27, 571-580. https://doi.org/10.1111/j.1365-2265.1987.tb01187.x
|
[52]
|
Flyckt, R.L., Liu, J., Frasure, H., Wekselman, K., Buch, A. and Kingsberg, S.A. (2009) Comparison of Salivary versus Serum Testosterone Levels in Postmenopausal Women Receiving Transdermal Testosterone Supplementation versus Placebo. Menopause, 16, 680-688. https://doi.org/10.1097/gme.0b013e318199d5c4
|
[53]
|
Hahn, A.K., Holmberg, K., Hammarstedt, J.E., Philp, F., DeMeo, P., Lai, V.J., et al. (2023) Intraobserver and Interobserver Reliability of the Snyder and Expanded SLAP Classification System: A Video Study. Orthopaedic Journal of Sports Medicine, 11, 1-8. https://doi.org/10.1177/23259671231204851
|